149 related articles for article (PubMed ID: 19732984)
1. Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT.
Van de Werf E; Lievens Y; Verstraete J; Pauwels K; Van den Bogaert W
Radiother Oncol; 2009 Oct; 93(1):137-40. PubMed ID: 19732984
[TBL] [Abstract][Full Text] [Related]
2. Fast, daily linac verification for segmented IMRT using electronic portal imaging.
Vieira SC; Bolt RA; Dirkx ML; Visser AG; Heijmen BJ
Radiother Oncol; 2006 Jul; 80(1):86-92. PubMed ID: 16854483
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance of intensity-modulated radiation therapy.
Palta JR; Liu C; Li JG
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S108-12. PubMed ID: 18406906
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
Stewart AJ; Lee YK; Saran FH
Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
[TBL] [Abstract][Full Text] [Related]
6. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
van Zijtveld M; Dirkx ML; de Boer HC; Heijmen BJ
Radiother Oncol; 2007 Feb; 82(2):201-7. PubMed ID: 17287039
[TBL] [Abstract][Full Text] [Related]
7. Dynamic targeting image-guided radiotherapy.
Huntzinger C; Munro P; Johnson S; Miettinen M; Zankowski C; Ahlstrom G; Glettig R; Filliberti R; Kaissl W; Kamber M; Amstutz M; Bouchet L; Klebanov D; Mostafavi H; Stark R
Med Dosim; 2006; 31(2):113-25. PubMed ID: 16690452
[TBL] [Abstract][Full Text] [Related]
8. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT.
McDermott LN; Wendling M; Sonke JJ; van Herk M; Mijnheer BJ
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1568-77. PubMed ID: 17394951
[TBL] [Abstract][Full Text] [Related]
9. Improvement of radiotherapy treatment delivery accuracy using an electronic portal imaging device.
Dirkx ML; de Boer JC; Heijmen BJ
Radiat Prot Dosimetry; 2006; 121(1):70-9. PubMed ID: 16877471
[TBL] [Abstract][Full Text] [Related]
10. SIFT: a method to verify the IMRT fluence delivered during patient treatment using an electronic portal imaging device.
Vieira SC; Dirkx ML; Heijmen BJ; de Boer HC
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):981-93. PubMed ID: 15465217
[TBL] [Abstract][Full Text] [Related]
11. The impact of introducing intensity modulated radiotherapy into routine clinical practice.
Miles EA; Clark CH; Urbano MT; Bidmead M; Dearnaley DP; Harrington KJ; A'Hern R; Nutting CM
Radiother Oncol; 2005 Dec; 77(3):241-6. PubMed ID: 16298002
[TBL] [Abstract][Full Text] [Related]
12. A clinical objective IMRT QA method based on portal dosimetry and electronic portal imager device (EPID) measurement.
Zhang M; Qin S; Chen T; Kim S; Jabbour S; Haffty B; Yue NJ
Technol Cancer Res Treat; 2013 Apr; 12(2):145-50. PubMed ID: 23289479
[TBL] [Abstract][Full Text] [Related]
13. [Application of amorphous silicon electronic portal imaging device (a-Si EPID) to dosimetry quality assurance of radiation therapy].
Chen MW; Deng XW; Huang SM; Chen L; Kang DH
Ai Zheng; 2007 Nov; 26(11):1272-5. PubMed ID: 17991332
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance in radiation oncology.
Hulick PR; Ascoli FA
J Am Coll Radiol; 2005 Jul; 2(7):613-6. PubMed ID: 17411887
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance of intensity-modulated radiotherapy.
Low DA
Semin Radiat Oncol; 2002 Jul; 12(3):219-28. PubMed ID: 12118387
[TBL] [Abstract][Full Text] [Related]
16. Automated analysis of images acquired with electronic portal imaging device during delivery of quality assurance plans for inversely optimized arc therapy.
Fredh A; Korreman S; Munck af Rosenschöld P
Radiother Oncol; 2010 Feb; 94(2):195-8. PubMed ID: 20122748
[TBL] [Abstract][Full Text] [Related]
17. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
18. Technological advancements and error rates in radiation therapy delivery.
Margalit DN; Chen YH; Catalano PJ; Heckman K; Vivenzio T; Nissen K; Wolfsberger LD; Cormack RA; Mauch P; Ng AK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e673-9. PubMed ID: 21669503
[TBL] [Abstract][Full Text] [Related]
19. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
20. Quality assurance analysis of a large multicenter practice: does increased complexity of intensity-modulated radiotherapy lead to increased error frequency?
Olson AC; Wegner RE; Scicutella C; Heron DE; Greenberger JS; Huq MS; Bednarz G; Flickinger JC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e77-82. PubMed ID: 21497453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
